nefazodone has been researched along with Disease Models, Animal in 3 studies
nefazodone: may be useful as an opiate adjunct
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gurjar, AS | 1 |
Darekar, MN | 1 |
Yeong, KY | 1 |
Ooi, L | 1 |
Dremencov, E | 1 |
Newman, ME | 1 |
Kinor, N | 1 |
Blatman-Jan, G | 1 |
Schindler, CJ | 1 |
Overstreet, DH | 1 |
Yadid, G | 1 |
Rojas-Corrales, MO | 1 |
Gibert-Rahola, J | 1 |
Mico, JA | 1 |
3 other studies available for nefazodone and Disease Models, Animal
Article | Year |
---|---|
In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; | 2018 |
Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Depression; Desipramine; Disease Mo | 2005 |
Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.
Topics: 5-Hydroxytryptophan; Analgesics, Opioid; Animals; Clozapine; Desipramine; Disease Models, Animal; Do | 2007 |